SAO Equity Snapshot

A1RG34 Weekly Equity Report

argenx SE

Latest Close 184.1 BRL 12 Jun 2026
1W Return 14.0% latest completed week
4W Return 14.9% short-term follow-through
12W Return 28.5% quarterly tape
Trend Breadth 50.0% 26 of 52 weeks active
Volume Ratio 2.0x vs 13-week average
Company Brief

What the company does

argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYVGART for the treatment of gMG and immune thrombocytopenia (ITP), and VYVGART HYTRULO for the treatment of gMG and chronic inflammatory demyelinating polyneuropathy (CIDP). It also develops efgartigimod for the treatment of seronegative gMG, ocular myasthenia gravis (MG), primary ITP, grave's disease, myositis, Sjögren's disease, systemic sclerosis, and AMR; empasiprubart for MMN, delayed graft function, and CIDP; and adimanebart for congenital myasthenic syndrome and spinal muscular atrophy. …

Snapshot

What the weekly tape is saying

A1RG34 closed the latest completed week at 184.1 BRL. The 4-week return is 14.9% and the 12-week return is 28.5%. Trend Signal is inactive, Market Dynamics is 0.56. Setup signature: Early recovery watch with a 72/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend 8.0%
Volume 2.0x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 28 Persistence of active Trend Signal over the last year and current streak.
Momentum 100 Blend of 4-week and 12-week follow-through.
Dynamics 81 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 78 Relative leadership and short-term RS change.
Volume 84 Participation compared with the 13-week volume baseline.
Risk Control 58 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
170.5 BRL
Vs Trend Line
8.0%
Fair Value
125.7 BRL
Vs Fair Value
46.4%
52W High
200.2 BRL
52W Low
116.9 BRL
Drawdown
-8.0%
Range Position
80.7%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 14.0%
4W 14.9%
12W 28.5%
26W -4.7%
52W 39.5%

Trend read

Active Streak
0 weeks
52W Active Weeks
26
52W Active Breadth
50.0%
Sector Scope
BR Healthcare
Sector Rank
3 of 80
Sector Percentile
97.5%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.56
4W MD Change
262.3%
Relative Strength
5.49
4W RS Change
148.8%
Expectation
Negative
Probability
38.27%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
1.0K
13W Average
520
52W Average
447
Vs 13W
2.0x
Vs 52W
2.3x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
6.0%
52W Volatility
5.2%
Upside Weeks
24
Downside Weeks
23
Downside Breadth
44.2%
Avg Gain / Loss
5.1% / -3.5%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
SAO
Country
BR
Sector
Healthcare
Industry
Biotechnology
Currency
BRL
Market Cap
261.7B

Opportunity signals

  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
  • Latest weekly return ranks in the strongest part of its sector group.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 184.1 BRL 14.0% 170.5 BRL 125.7 BRL 0.56 5.49 1.0K Off
5 Jun 2026 161.5 BRL -4.1% 170.7 BRL 125.0 BRL 0.21 -6.12 621 Off
29 May 2026 168.3 BRL 5.0% 171.4 BRL 124.5 BRL 0.01 -4.86 918 Off
22 May 2026 160.3 BRL 0.0% 171.4 BRL 123.9 BRL -0.31 -10.63 0 Off
15 May 2026 160.3 BRL 3.7% 171.9 BRL 123.4 BRL -0.35 -11.25 310 Off
8 May 2026 154.5 BRL -1.6% 172.6 BRL 122.9 BRL -0.25 -17.65 635 Off
1 May 2026 156.9 BRL -0.2% 173.3 BRL 122.4 BRL -0.45 -17.90 322 Off
24 Apr 2026 157.2 BRL -7.3% 173.7 BRL 121.9 BRL -0.67 -19.63 1.4K Off
17 Apr 2026 169.6 BRL 10.2% 173.7 BRL 121.4 BRL -0.98 -15.84 1.5K Off
10 Apr 2026 153.9 BRL 7.5% 173.2 BRL 120.9 BRL -1.40 -24.54 1 Off
3 Apr 2026 143.2 BRL 0.0% 173.5 BRL 120.4 BRL -1.44 -26.71 0 Off
27 Mar 2026 143.2 BRL 0.0% 173.9 BRL 120.0 BRL -1.34 -24.49 0 Off
20 Mar 2026 143.2 BRL -5.7% 174.3 BRL 119.6 BRL -1.23 -22.54 1 Off
13 Mar 2026 151.8 BRL -2.1% 174.3 BRL 119.2 BRL -1.10 -18.94 81 Off